The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Peptides as Targeting Elements and Tissue Penetration Devices for Nanoparticles
Open accessAbstract
The use of nanoparticles in medicine (nanomedicine) has recently become an intensely studied field. Nanoparticles carrying drugs and imaging agents have already reached the clinic, but they are essentially passive delivery vehicles, not what are referred to as “smart” nanoparticles. An important function to add to make nanoparticles smarter is active homing to the target tissue. It makes nanoparticles accumulate in the target tissue at higher concentrations than would be the case without this feature, increasing therapeutic efficacy and reducing side effects. This review discusses the recent developments in the nanoparticle targeting field with emphasis on peptides that home to vascular “zip codes” in target tissues and provide a tissue‐ and cell‐penetrating function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054
Self-citationBiodegradable luminescent porous silicon nanoparticles for in vivo applications
Park, J.-H., Gu, L., von Maltzahn, G., Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2009) · Nature Materials · doi:10.1038/nmat2398 · Cited by 1,897
Self-citationExploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Tumor angiogenesis: molecular pathways and therapeutic targets
Weis, S. M., & Cheresh, D. A. (2011) · Nature Medicine · doi:10.1038/nm.2537 · Cited by 1,736
Åkerman, M. E., Chan, W. C. W., Laakkonen, P., Bhatia, S. N., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152463399 · Cited by 1,437
Self-citationTransvascular delivery of small interfering RNA to the central nervous system
Kumar, P., Wu, H., McBride, J. L., Jung, K.-E., Hee Kim, M., Davidson, B. L., Kyung Lee, S., Shankar, P., & Manjunath, N. (2007) · Nature · doi:10.1038/nature05901 · Cited by 1,246
Organ targeting In vivo using phage display peptide libraries
Pasqualini, R., & Ruoslahti, E. (1996) · Nature · doi:10.1038/380364a0 · Cited by 1,221
Self-citationTissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Girard, O. M., Hanahan, D., Mattrey, R. F., & Ruoslahti, E. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.013 · Cited by 1,136
Self-citationCoadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Greenwald, D. R., & Ruoslahti, E. (2010) · Science · doi:10.1126/science.1183057 · Cited by 1,075
Self-citationAminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R., Shapiro, L., Arap, W., & Ruoslahti, E. I. (2000) · PubMed · Cited by 966
Self-citationAnti-cancer activity of targeted pro-apoptotic peptides
Ellerby, H. M., Arap, W., Ellerby, L. M., Kain, R., Andrusiak, R., Rio, G. D., Krajewski, S., Lombardo, C. R., Rao, R., Ruoslahti, E., et al. (1999) · Nature Medicine · doi:10.1038/12469 · Cited by 936
Self-citationTargeting of drugs and nanoparticles to tumors
Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200910104 · Cited by 829
Self-citationTumor imaging by means of proteolytic activation of cell-penetrating peptides
Jiang, T., Olson, E. S., Nguyen, Q. T., Roy, M., Jennings, P. A., & Tsien, R. Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408191101 · Cited by 822
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration
Teesalu, T., Sugahara, K. N., Kotamraju, V. R., & Ruoslahti, E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908201106 · Cited by 812
Self-citationMolecular mechanisms of lymphangiogenesis in health and disease
Alitalo, K., & Carmeliet, P. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00051-x · Cited by 734
Specialization of tumour vasculature
Ruoslahti, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc724 · Cited by 722
Self-citationTransport of Molecules, Particles, and Cells in Solid Tumors
Jain, R. K. (1999) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.1.1.241 · Cited by 691
Kang, B., Mackey, M. A., & El-Sayed, M. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja9102698 · Cited by 674
Reversal of obesity by targeted ablation of adipose tissue
Kolonin, M. G., Saha, P. K., Chan, L., Pasqualini, R., & Arap, W. (2004) · Nature Medicine · doi:10.1038/nm1048 · Cited by 601
Intracellular Delivery of Quantum Dots for Live Cell Labeling and Organelle Tracking
Derfus, A. M., Chan, W. C. W., & Bhatia, S. N. (2004) · Advanced Materials · doi:10.1002/adma.200306111 · Cited by 549
Transdifferentiation of glioblastoma cells into vascular endothelial cells
Soda, Y., Marumoto, T., Friedmann-Morvinski, D., Soda, M., Liu, F., Michiue, H., Pastorino, S., Yang, M., Hoffman, R. M., Kesari, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016030108 · Cited by 515
Nanoparticles that communicate in vivo to amplify tumour targeting
Park, J., Lin, K., Singh, N., Schwöppe, C., Mesters, R. M., Berdel, W. E., Ruoslahti, E. I., Sailor, M. J., von Maltzhan, G., & Bhatia, S. N. (2010) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 500
Self-citationA tumor-homing peptide with a targeting specificity related to lymphatic vessels
Laakkonen, P., Porkka, K., Hoffman, J. A., & Ruoslahti, E. (2002) · Nature Medicine · doi:10.1038/nm720 · Cited by 498
Self-citationA biocompatible condensation reaction for controlled assembly of nanostructures in living cells
Liang, G., Ren, H., & Rao, J. (2010) · Nature Chemistry · doi:10.1038/nchem.480 · Cited by 497
Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels
Christian, S., Pilch, J., Akerman, M. E., Porkka, K., Laakkonen, P., & Ruoslahti, E. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304132 · Cited by 497
Self-citationVascular Targeted Nanoparticles for Imaging and Treatment of Brain Tumors
Reddy, G. R., Bhojani, M. S., McConville, P., Moody, J., Moffat, B. A., Hall, D. E., Kim, G., Koo, Y.-E. L., Woolliscroft, M. J., Sugai, J. V., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0946 · Cited by 491
Oh, P., Li, Y., Yu, J., Durr, E., Krasinska, K. M., Carver, L. A., Testa, J. E., & Schnitzer, J. E. (2004) · Nature · doi:10.1038/nature02580 · Cited by 475
Biomimetic amplification of nanoparticle homing to tumors
Simberg, D., Duza, T., Park, J. H., Essler, M., Pilch, J., Zhang, L., Derfus, A. M., Yang, M., Hoffman, R. M., Bhatia, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610298104 · Cited by 471
Self-citationvon Maltzahn, G., Centrone, A., Park, J., Ramanathan, R., Sailor, M. J., Hatton, T. A., & Bhatia, S. N. (2009) · Advanced Materials · doi:10.1002/adma.200803464 · Cited by 455
Genes that Distinguish Physiological and Pathological Angiogenesis
Seaman, S., Stevens, J., Yang, M. Y., Logsdon, D., Graff-Cherry, C., & St. Croix, B. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.017 · Cited by 419
Cell surface tumor endothelial markers are conserved in mice and humans.
Carson-Walter, E. B., Watkins, D. N., Nanda, A., Vogelstein, B., Kinzler, K. W., & Croix, B. S. (2001) · PubMed · Cited by 414
Metadherin, a cell surface protein in breast tumors that mediates lung metastasis
Brown, D. M., & Ruoslahti, E. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00079-0 · Cited by 385
Self-citationTAT transduction: the molecular mechanism and therapeutic prospects
Gump, J. M., & Dowdy, S. F. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.08.002 · Cited by 356
Development of a novel mouse glioma model using lentiviral vectors
Marumoto, T., Tashiro, A., Friedmann-Morvinski, D., Scadeng, M., Soda, Y., Gage, F. H., & Verma, I. M. (2009) · Nature Medicine · doi:10.1038/nm.1863 · Cited by 353
Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma
Agemy, L., Friedmann-Morvinski, D., Kotamraju, V. R., Roth, L., Sugahara, K. N., Girard, O. M., Mattrey, R. F., Verma, I. M., & Ruoslahti, E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114518108 · Cited by 347
Self-citationMitochondrial/Cell-Surface Protein p32/gC1qR as a Molecular Target in Tumor Cells and Tumor Stroma
Fogal, V., Zhang, L., Krajewski, S., & Ruoslahti, E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6752 · Cited by 346
Self-citationMacrophages Recognize Size and Shape of Their Targets
Doshi, N., & Mitragotri, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010051 · Cited by 321
Abe, K., Shoji, M., Chen, J., Bierhaus, A., Danave, I., Micko, C., Casper, K., Dillehay, D. L., Nawroth, P. P., & Rickles, F. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8663 · Cited by 312
Cooperative nanomaterial system to sensitize, target, and treat tumors
Park, J.-H., von Maltzahn, G., Xu, M. J., Fogal, V., Kotamraju, V. R., Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909565107 · Cited by 307
Self-citationSoman, N. R., Baldwin, S. L., Hu, G., Marsh, J. N., Lanza, G. M., Heuser, J. E., Arbeit, J. M., Wickline, S. A., & Schlesinger, P. H. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38842 · Cited by 293
Systematic Surface Engineering of Magnetic Nanoworms for In vivo Tumor Targeting
Park, J., von Maltzahn, G., Zhang, L., Derfus, A. M., Simberg, D., Harris, T. J., Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2009) · Small · doi:10.1002/smll.200801789 · Cited by 293
Self-citationPorkka, K., Laakkonen, P., Hoffman, J. A., Bernasconi, M., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062189599 · Cited by 291
Self-citationTargeting the prostate for destruction through a vascular address
Arap, W., Haedicke, W., Bernasconi, M., Kain, R., Rajotte, D., Krajewski, S., Ellerby, H. M., Bredesen, D. E., Pasqualini, R., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241655998 · Cited by 285
Self-citationTargeting atherosclerosis by using modular, multifunctional micelles
Peters, D., Kastantin, M., Kotamraju, V. R., Karmali, P. P., Gujraty, K., Tirrell, M., & Ruoslahti, E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903369106 · Cited by 271
Self-citationAuerbach, R., Lu, W., Pardon, E., Gumkowski, F., Kamińska, G., & Kamiński, M. (1987) · PubMed · Cited by 251
Regulation of Extravascular Coagulation by Microvascular Permeability
Dvorak, H. F., Senger, D. R., Dvorak, A. M., Harvey, V. S., & McDonagh, J. (1985) · Science · doi:10.1126/science.3975602 · Cited by 247
Targeted Nanoparticles for Imaging Incipient Pancreatic Ductal Adenocarcinoma
Kelly, K. A., Bardeesy, N., Anbazhagan, R., Gurumurthy, S., Berger, J., Alencar, H., DePinho, R. A., Mahmood, U., & Weissleder, R. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050085 · Cited by 240
Targeting of albumin-embedded paclitaxel nanoparticles to tumors
Karmali, P. P., Kotamraju, V. R., Kastantin, M., Black, M., Missirlis, D., Tirrell, M., & Ruoslahti, E. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.07.007 · Cited by 234
Self-citationTranstumoral targeting enabled by a novel neuropilin-binding peptide
Roth, L., Agemy, L., Kotamraju, V. R., Braun, G., Teesalu, T., Sugahara, K. N., Hamzah, J., & Ruoslahti, E. (2012) · Oncogene · doi:10.1038/onc.2011.537 · Cited by 231
Self-citationProgressive vascular changes in a transgenic mouse model of squamous cell carcinoma
Hoffman, J. A., Giraudo, E., Singh, M., Zhang, L., Inoue, M., Porkka, K., Hanahan, D., & Ruoslahti, E. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00273-3 · Cited by 224
Self-citationKinsella, J. M., Jimenez, R. E., Karmali, P. P., Rush, A. M., Kotamraju, V. R., Gianneschi, N. C., Ruoslahti, E., Stupack, D., & Sailor, M. J. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201104507 · Cited by 224
Self-citationJoyce, J. A., Laakkonen, P., Bernasconi, M., Bergers, G., Ruoslahti, E., & Hanahan, D. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00271-x · Cited by 211
Self-citationInduction of Cancer Cell Death by Self-assembling Nanostructures Incorporating a Cytotoxic Peptide
Standley, S. M., Toft, D. J., Cheng, H., Soukasene, S., Chen, J., Raja, S. M., Band, V., Band, H., Cryns, V. L., & Stupp, S. I. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3267 · Cited by 198
The RGD story: a personal account
Ruoslahti, E. (2003) · Matrix Biology · doi:10.1016/s0945-053x(03)00083-0 · Cited by 189
Self-citationNanoparticle-induced vascular blockade in human prostate cancer
Agemy, L., Sugahara, K. N., Kotamraju, V. R., Gujraty, K., Girard, O. M., Kono, Y., Mattrey, R. F., Park, J.-H., Sailor, M. J., Jimenez, A. I., et al. (2010) · Blood · doi:10.1182/blood-2010-03-274258 · Cited by 170
Self-citationRajotte, D., & Ruoslahti, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11593 · Cited by 166
Self-citationPeptides selected for binding to clotted plasma accumulate in tumor stroma and wounds
Pilch, J., Brown, D. M., Komatsu, M., Järvinen, T. A. H., Yang, M., Peters, D., Hoffman, R. M., & Ruoslahti, E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511219103 · Cited by 162
Self-citationVascular zip codes in angiogenesis and metastasis
Ruoslahti, E. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320397 · Cited by 158
Self-citationBagri, A., Tessier‐Lavigne, M., & Watts, R. J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0563 · Cited by 154
Chan, J. M., Rhee, J., Drum, C. L., Bronson, R. T., Golomb, G., Langer, R., & Farokhzad, O. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115945108 · Cited by 143
Bieker, R., Keßler, T., Schwöppe, C., Padró, T., Persigehl, T., Bremer, C., Dreischalück, J., Kolkmeyer, A., Heindel, W. L., Mesters, R. M., et al. (2009) · Blood · doi:10.1182/blood-2008-04-150318 · Cited by 139
The Anti-HIV Cytokine Midkine Binds the Cell Surface-expressed Nucleolin as a Low Affinity Receptor
Said, E. A., Krust, B., Nisole, S., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201194200 · Cited by 138
Coupling Tumor Necrosis Factor-α with αV Integrin Ligands Improves Its Antineoplastic Activity
Curnis, F., Gasparri, A. M., Sacchi, A., Longhi, R., & Corti, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1753 · Cited by 138
Design of a Tumor-Homing Cell-Penetrating Peptide
Myrberg, H., Zhang, L., Mäe, M. A., & Langel, Ü. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0701139 · Cited by 137
Controlling Intracellular Macrocyclization for the Imaging of Protease Activity
Ye, D., Liang, G., Ma, M. L., et al. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201006140 · Cited by 136
Tan, M., Lan, K., Yao, J., Lu, C., Sun, M., Neal, C. L., Lü, J., & Yu, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2747 · Cited by 129
Ché, C., Yang, G., Thiot, C., Lacoste, M.-C., Currie, J.-C., Demeule, M., Régina, A., Béliveau, R., & Castaigne, J.-P. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm9016637 · Cited by 123
Hamzah, J., Kotamraju, V. R., Seo, J. W., Agemy, L., Fogal, V., Mahakian, L. M., Peters, D., Roth, L., Gagnon, M.-H., Ferrara, K. W., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104540108 · Cited by 122
Self-citationUchida, M., Kosuge, H., Terashima, M., Willits, D. A., Liepold, L. O., Young, M., McConnell, M. V., & Douglas, T. (2011) · ACS Nano · doi:10.1021/nn102863y · Cited by 116
Mapping of Vascular ZIP Codes by Phage Display
Teesalu, T., Sugahara, K. N., & Ruoslahti, E. I. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-396962-0.00002-1 · Cited by 112
Self-citationMolecular Profiling of Heart Endothelial Cells
Zhang, L., Hoffman, J. A., & Ruoslahti, E. I. (2005) · Circulation · doi:10.1161/circulationaha.104.529537 · Cited by 107
Self-citationWiner, I. S., Wang, S., Lee, Y.-E. K., Fan, W., Gong, Y., Burgos-Ojeda, D., Spahlinger, G., Kopelman, R., & Buckanovich, R. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1917 · Cited by 102
Ye, F., Jeong, E., Jia, Z., Yang, T., Parker, D., & Lu, Z. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800211r · Cited by 100
Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide
Hatakeyama, S., Sugihara, K., Shibata, T. K., Nakayama, J., Akama, T. O., Tamura, N., Wong, S.-M., Bobkov, A. A., Takano, Y., Οhyama, C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105057108 · Cited by 98
Improved Brain Delivery of Benzylpenicillin with a Peptide-vector-mediated Strategy
Rousselle, C., Clair, P., Temsamani, J., & Scherrmann, J. (2002) · Journal of drug targeting · doi:10.1080/10611860290031886 · Cited by 84
Molecular Changes in the Vasculature of Injured Tissues
Järvinen, T. A. H., & Ruoslahti, E. I. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061251 · Cited by 74
Self-citationTumor Vasculature Targeting Through NGR Peptide-Based Drug Delivery Systems
Corti, A., & Curnis, F. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111796117373 · Cited by 70
Peptide-Directed Highly Selective Targeting of Pulmonary Arterial Hypertension
Urakami, T., Järvinen, T. A. H., Toba, M., Sawada, J., Ambalavanan, N., Mann, D., McMurtry, I. F., Oka, M., Ruoslahti, E. I., & Komatsu, M. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.02.032 · Cited by 59
Self-citationGregorc, V., Citterio, G., Vitali, G., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.10.005 · Cited by 54
Jacobson, B. S., Stolz, D. B., & Schnitzer, J. E. (1996) · Nature Medicine · doi:10.1038/nm0496-482 · Cited by 48
A Proteomic Approach for the Identification of Vascular Markers of Liver Metastasis
Borgia, B., Roesli, C., Fugmann, T., Schliemann, C., Cesca, M., Neri, D., & Giavazzi, R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2939 · Cited by 42
Peptides targeting inflamed synovial vasculature attenuate autoimmune arthritis
Yang, Y.-H., Rajaiah, R., Ruoslahti, E. I., & Moudgil, K. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103569108 · Cited by 42
Self-citationFurin Targeted Drug Delivery for Treatment of Rhabdomyosarcoma in a Mouse Model
Hajdin, K., D’Alessandro, V., Niggli, F. K., Schäfer, B. W., & Bernasconi, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010445 · Cited by 35
Cited by
Anselmo, A. C., & Mitragotri, S. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10003 · Cited by 1,321
Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review
Hossen, S., Hossain, M. K., Basher, M. K., Mia, M. N. H., Rahman, M. T., & Uddin, M. J. (2019) · Journal of Advanced Research · doi:10.1016/j.jare.2018.06.005 · Cited by 998
Nanomedicine therapeutic approaches to overcome cancer drug resistance
Markman, J. L., Rekechenetskiy, A., Holler, E., & Ljubimova, J. Y. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.019 · Cited by 733
“Further, these peptides may not only play a role in homing but in tumor-penetration, as is the case with iRGD, because they allow for the exit from blood vessels and can activate a tissue-specific transport pathway [105], which is a big advantage in treating resistant tumors.”
BackgroundMethodMesoporous silica nanoparticles in medicine—Recent advances
Mamaeva, V., Sahlgren, C., & Lindén, M. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.018 · Cited by 707
Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium
Kolhar, P., Anselmo, A. C., Gupta, V., Pant, K., Prabhakarpandian, B., Ruoslahti, E., & Mitragotri, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308345110 · Cited by 646
Self-citation
Metadata
- Authors
- Ruoslahti, E.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2012-05-02
- Volume
- 24
- Issue
- 28
- Pages
- 3747-3756
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W2082575848
- Cited by
- 419
- References
- 88
- FWCI
- 12.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.